Phase 1 Drug-drug Interaction Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Drug-Drug Interaction Study of ABP-671 in Gout Patients

GoutGout ChronicDDI (Drug-Drug Interaction)

Atom Therapeutics Co., Ltd20 enrolled1 locationNCT07367971

Recruiting

Phase 1

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Healthy VolunteerSafetyPharmacokinetics+2 more

Basilea Pharmaceutica46 enrolled1 locationNCT06733675

Recruiting

Phase 1

to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban

Drug-Drug Interaction (DDI)

Onconic Therapeutics Inc.96 enrolled1 locationNCT07265466